Glaxo ‘turns back the clock’ and resumes payments to doctors

first_img GET STARTED Glaxo ‘turns back the clock’ and resumes payments to doctors In an unexpected move, GlaxoSmithKline (GSK) will resume payments to doctors who help promote some of their medicines, reversing a policy begun five years ago after marketing scandals that led, in part, to an infamous settlement with U.S. authorities.Going forward, the company will pay doctors who speak on its behalf for “select” products in the U.S. and Japan, but this could extend to major markets in Europe, North America, and Asia starting next year. Nonetheless, Glaxo insisted total payments will be “significantly lower” than before the old policy was announced in 2013. Ed Silverman Sang Tan/AP Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Pharmalot center_img [email protected] What is it? By Ed Silverman Oct. 2, 2018 Reprints About the Author Reprints What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. @Pharmalot Tags pharmaceuticalsphysiciansSTAT+last_img

Leave a Reply

Your email address will not be published. Required fields are marked *